Literature DB >> 14605064

Do all nonsurvivors of cardiogenic shock die with a low cardiac index?

Noelle Lim1, Marc-Jacques Dubois, Daniel De Backer, Jean-Louis Vincent.   

Abstract

STUDY
OBJECTIVES: To characterize the hemodynamic course of cardiogenic shock and to relate the cause of death to ongoing cardiac failure or multiple organ dysfunction.
DESIGN: Retrospective study.
SETTING: A 31-bed department of intensive care in a university hospital. PATIENTS: All patients admitted for cardiogenic shock from January 1999 to December 2000.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: Charts were reviewed for demographic, clinical, hemodynamic, oxygen transport, inflammation, and organ dysfunction data. Of 62 patients with cardiogenic shock, 40 (65%) did not survive. Eight patients (20%) died from fatal arrhythmia, 14 patients (35%) died with low cardiac index (CI) [ie, < 2.2 L/min/m(2)], and 18 patients (45%) died with normalized CI (ie, > 2.2 L/min/m(2)) and a higher CI/oxygen extraction ratio. Of these 18 patients, 9 had evidence of infection. The patients with normalized CI were younger and stayed longer in the ICU than patients with low CI.
CONCLUSION: A substantial number of patients with cardiogenic shock die with a normalized CI, suggesting a distributive defect, in the absence of obvious infection. These patients are younger and have a longer ICU course. The release of mediators may be secondary to gut hypoperfusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605064     DOI: 10.1378/chest.124.5.1885

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Cardiogenic shock--an inflammatory disease.

Authors:  Gottfried Heinz
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

Review 2.  Cardiogenic shock and nutrition: safe?

Authors:  Ronan Thibault; Claude Pichard; Jan Wernerman; Karim Bendjelid
Journal:  Intensive Care Med       Date:  2010-11-18       Impact factor: 17.440

Review 3.  Oxygen transport-the oxygen delivery controversy.

Authors:  Jean-Louis Vincent; Daniel De Backer
Journal:  Intensive Care Med       Date:  2004-07-16       Impact factor: 17.440

Review 4.  Cardiogenic Shock: Failure of Oxygen Delivery and Oxygen Utilization.

Authors:  Hoong Sern Lim
Journal:  Clin Cardiol       Date:  2016-08-10       Impact factor: 2.882

5.  Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure.

Authors:  Corstiaan A den Uil; Kadir Caliskan; Wim K Lagrand; Martin van der Ent; Lucia S D Jewbali; Jan P van Kuijk; Peter E Spronk; Maarten L Simoons
Journal:  Intensive Care Med       Date:  2009-07-29       Impact factor: 17.440

Review 6.  Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.

Authors:  Susanne Unverzagt; Michael Buerke; Antoinette de Waha; Johannes Haerting; Diana Pietzner; Melchior Seyfarth; Holger Thiele; Karl Werdan; Uwe Zeymer; Roland Prondzinsky
Journal:  Cochrane Database Syst Rev       Date:  2015-03-27

7.  Skeletal muscle oxygen saturation does not estimate mixed venous oxygen saturation in patients with severe left heart failure and additional severe sepsis or septic shock.

Authors:  Matej Podbregar; Hugon Mozina
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

8.  The acute phase of experimental cardiogenic shock is counteracted by microcirculatory and mitochondrial adaptations.

Authors:  Thor Allan Stenberg; Anders Benjamin Kildal; Espen Sanden; Ole-Jakob How; Martin Hagve; Kirsti Ytrehus; Terje S Larsen; Truls Myrmel
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

9.  Searching for an ideal hemodynamic marker to predict short-term outcome in cardiogenic shock.

Authors:  Mehmet Birhan Yilmaz; Alexandre Mebazaa
Journal:  Crit Care       Date:  2009       Impact factor: 9.097

10.  Microcirculation in cardiogenic shock supported with extracorporeal membrane oxygenation: the need for a homogeneous population and strict evolution assessment.

Authors:  Santiago Montero; Juliette Chommeloux; Guillaume Franchineau; Alain Combes; Matthieu Schmidt
Journal:  Crit Care       Date:  2018-10-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.